A stroke therapy using stem cells extracted from patients’ bone marrow has shown promising results in the first trial of its kind in humans.
The therapy was found to be safe, and all the patients showed improvements in clinical measures of disability.
The findings are published in the journal Stem Cells Translational Medicine. It is the first UK human trial of a stem cell treatment for acute stroke to be published.
The therapy uses a type of cell called CD34+ cells, a set of stem cells in the bone marrow that give rise to blood cells and blood vessel lining cells. Previous research has shown that treatment using these cells can significantly improve recovery from stroke in animals. Rather than developing into brain cells themselves, the cells are thought to release chemicals that trigger the growth of new brain tissue and new blood vessels in the area damaged by stroke.
The Latest on: Stroke therapy
via Google News
The Latest on: Stroke therapy
- Stroke: Timely intervention is crucialon December 3, 2021 at 4:00 pm
A STROKE is a medical emergency. It needs to be treated promptly to improve a patient's chance of survival and lower the risk of long-term brain damage. It occurs when blood supply to part of the ...
- Insurance Covered CPAP Offers Important Information on CPAP Sleep Therapyon December 3, 2021 at 10:45 am
Insurance Covered CPAP has provided important information on CPAP sleep therapy through a blog post on its website. Continuous positive airway pressure (CPAP) therapy is a kind of treatment with the ...
- New Zealand's Cairns not sure he will walk again after spinal strokeon December 3, 2021 at 12:03 am
Former New Zealand all-rounder Chris Cairns said he is not sure if he will walk again but that he is lucky to be alive after suffering a spinal stroke following life-saving treatment for a torn artery ...
- ZZ Biotech Announces First Patients Dosed in Phase 2 Clinical Trial of 3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)on December 2, 2021 at 4:17 am
ZZ Biotech Announces First Patients Dosed in Phase 2 Clinical Trial of 3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS) ...
- Groton biotech firm working on much-needed drug to treat stroke, brain injurieson December 1, 2021 at 9:01 pm
GROTON — A small drug development company that moved its headquarters from Cambridge, Mass., to the BioCT Innovations Commons on Shennecossett Road last year is aiming to have a huge impact on the ...
- Fast-tracked human stroke drug may also be a safe and powerful defense against dementiaon December 1, 2021 at 4:52 pm
A human stroke drug, fast-tracked by the Food and Drug Administration and soon entering Phase 3 clinical trials, shows intriguing signs that it might also be a safe and powerful defense against ...
- Magnetic resonance imaging and artificial intelligence can detect early signs of tumor cell death after novel therapyon December 1, 2021 at 12:29 pm
In a recent study published in Nature Biomedical Engineering, a team led by researchers at Massachusetts General Hospital (MGH) has demonstrated that magnetic resonance imaging (MRI) and artificial ...
- Meet a 10-year-old stroke survivoron November 29, 2021 at 2:40 pm
Content by Sanford Health. This North Dakota family traveled three states to save their daughter’s life and continue her recovery.
- Assessing optimal stroke treatment using CTA imagingon November 29, 2021 at 8:19 am
Professor Gilberto Gonzalez discusses using a common imaging technique to decide on the best course of treatment for large vessel occlusion stroke patients.
- Remedial therapy after stroke: a randomised controlled trial.on November 27, 2021 at 9:13 am
Of 1094 patients with a confirmed stroke admitted to Northwick Park, a district general hospital, 364 (33%) died while in hospital, 215 (20%) were fully recovered when discharged, and 329 (30%) were ...
via Bing News